Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

ImmuneBiotech Medical Sweden AB

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 2,861 Less Arrow 2,282 Less Arrow 1,602
Financial expenses 0 Equal arrow 0 More Arrow 12
Earnings before taxes -7,553 More Arrow -5,467 Less Arrow -5,490
EBITDA -7,783 More Arrow -5,360 More Arrow -5,323
Total assets 15,059 More Arrow 21,055 Less Arrow 7,347
Current assets 15,005 More Arrow 20,880 Less Arrow 7,040
Current liabilities 845 Less Arrow 730 Less Arrow 464
Equity capital 14,214 More Arrow 20,325 Less Arrow 6,883
- share capital 75 Less Arrow 70 Less Arrow 65
Employees (average) 3 Less Arrow 2 Less Arrow 1

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 94.4% More Arrow 96.5% Less Arrow 93.7%
Turnover per employee 954 More Arrow 1,141 More Arrow 1,602
Profit as a percentage of turnover -264.0% More Arrow -239.6% Less Arrow -342.7%
Return on assets (ROA) -50.2% More Arrow -26.0% Less Arrow -74.6%
Current ratio 1775.7% More Arrow 2860.3% Less Arrow 1517.2%
Return on equity (ROE) -53.1% More Arrow -26.9% Less Arrow -79.8%
Change turnover 417 More Arrow 727 More Arrow 928
Change turnover % 17% More Arrow 47% More Arrow 138%
Chg. No. of employees 1 Equal arrow 1 Less Arrow 0
Chg. No. of employees % 50% More Arrow 100% Less Arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.